GSTM1 and myeloproliferative disorder: Univariate analysis was performed for the whole cohort of 857 AML patients in terms of age, WBC count, Hb, platelet count, history of MDS or MDS/MPN, MDS-related cytogenetic abnormalities, MLD, LDH, and MRC.